IPP Bureau
NVIDIA partners with Novo Nordisk and DCAI to advance drug discovery
By IPP Bureau - June 13, 2025
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
FDA approves AbbVie’s mavyret as first and only treatment for acute hepatitis C
By IPP Bureau - June 13, 2025
Now approved for both acute and chronic HCV in adults and children aged 3 and above
Sigachi Industries gets ToR approval for API and specialty chemicals manufacturing facility in Andhra Pradesh
By IPP Bureau - June 13, 2025
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Cipla Health launches a new campaign for Cipladine with Neena Gupta as brand ambassador
By IPP Bureau - June 13, 2025
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
IOL Chemicals and Pharmaceuticals bags EcoVadis silver medal
By IPP Bureau - June 13, 2025
Ranks among the top 15% companies globally
USFDA inspection at the API manufacturing plant located in Mekaguda, Hyderabad
By IPP Bureau - June 13, 2025
The company received 1 (One) observation in the Form-483
Sun Pharma appoints Kirti Ganorkar as the Managing Director
By IPP Bureau - June 13, 2025
Dilip Shanghvi to continue as the Executive Chairman of the Board
Zydus receives EIR for the API manufacturing facility at Ankleshwar and Dabhasa
By IPP Bureau - June 12, 2025
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Aayush Wellness to form subsidiary in Singapore to drive Southeast Asia expansion
By IPP Bureau - June 12, 2025
This strategic expansion marks a significant step in the company's global growth strategy
Boehringer Ingelheim and Eko Health collaborate to improve heart murmur detection in dogs
By IPP Bureau - June 12, 2025
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
FDA approves Merck’s enflonsia for prevention of RSV in infants
By IPP Bureau - June 12, 2025
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Biocon Foundation launches BioWISE Program to empower women in STEM
By IPP Bureau - June 11, 2025
25 women students to receive internship, training, and mentorship in Life Sciences segment
Lubrizol's polymer excipient Apisolex featured in Phase I candidate
By IPP Bureau - June 11, 2025
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
